Results 241 to 250 of about 110,409 (295)

Intrapleural injection of Folactis promotes regression of malignant pleural effusion: a case of malignant pleural mesothelioma and the review of literatures

Naiqing Ding, Shu Su, Baorui Liu, Lifeng Wang   +3 more
openalex   +1 more source

Peritoneal Mesothelioma Diagnosed on Frozen Section During Diagnostic Laparoscopy: A Case Report. [PDF]

Cureus
Visconti M, Watts JM, Weston W, Cimino JF, Englund G, Jarosz M.   +5 more
europepmc   +1 more source

Diagnostic and Therapeutic Management of Mesothelioma of the Tunica Vaginalis Testis: A Population-Based Study in Italy. [PDF]

Cancers (Basel)
Ceresoli GL, Stella S, Dallari B, Perduri R, Storchi C, Vimercati L, Piro S, Giovannetti L, Fedeli U, Casotto V, Migliore E, Stura A, Genova C, Benfatto L, Larese Filon F, D'Agostin F, Cozzi I, Angelillo IF, Spata E, Murano S, Grappasonni I, Pascucci C, Melis M, Stracci F, Marinaccio A, Binazzi A, Consonni D, Mensi C.   +27 more
europepmc   +1 more source

The evolution of an epidemic: age-period-cohort modelling of mesothelioma in Casale Monferrato, 1990-2021, with projections to 2042. [PDF]

Environ Health
Giraldo M, Zugna D, Migliore E, Ramos-Bonilla JP, Maule M.   +4 more
europepmc   +1 more source

Extrapleural radical pneumonectomy for treatment of diffuse malignant pleural mesothelioma: Report of a case and literature review

, 2006
Tsai Wang Huang, Ching Tzao, Shih Chun Lee, Chih Kung Lin, Yeung Leung Cheng   +4 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pleural mesothelioma

Medicina Clínica (English Edition), 2022
The diagnosis of diffuse pleural mesothelioma requires in most cases a pleural biopsy, performed either under imaging guidance (ultrasound or computed tomography) or thoracoscopy. Loss of BAP1 or MTAP expression (immunohistochemistry) and homozygous deletion of CDKN2A (fluorescence in situ hybridization) are the basic molecular markers for the ...
openaire   +2 more sources

Malignant mesothelioma

Internal Medicine Journal, 2010
AbstractMalignant mesothelioma (MM) is an aggressive tumour that commonly affects the mesothelial surfaces of the pleural and peritoneal cavities, and occasionally, the tunica vaginalis and the pericardium. Formerly a rare tumour, MM is increasing in incidence in Australia due to the heavy nationwide use of asbestos from 1940 until the 1980s.
S C-H, Kao, G, Reid, K, Lee, J, Vardy, S, Clarke, N, van Zandwijk   +5 more
openaire   +2 more sources

Paratesticular Mesotheliomas

Journal of Urology, 1983
Paratesticular mesotheliomas are uncommon tumors. We report 2 such cases and discuss their clinical and pathological findings.
R E, McDonald, A L, Sago, D E, Novicki, J W, Bagnall   +3 more
openaire   +2 more sources

Pleural Mesothelioma

Scandinavian Journal of Thoracic and Cardiovascular Surgery, 1980
The difficulties in diagnosing pleural mesothelioma, both clinically and histopathologically, are documented by our experiences with this rare tumour during an 18-year-period. A rising incidence of pleural mesothelioma is reported in the literature, which is suspected to be caused by the increasing use of asbestos. This increase is not represented in a
H, Vejlsted, B F, Hansen
openaire   +2 more sources

Pericardial mesothelioma

Current Treatment Options in Oncology, 2000
Primary pericardial mesothelioma is a rare but lethal disease. Altogether there are about 150 cases reported in the literature. In most cases the diagnosis is made at autopsy or postoperatively. Clinical signs and symptoms are typically nonspecific and are similar to compromised cardiac function.
W T, Vigneswaran, P R, Stefanacci
openaire   +2 more sources